This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Community Health (CYH) Q1 Earnings Beat, Trims '22 EPS View
by Zacks Equity Research
Community Health's (CYH) first-quarter results benefit on the back of higher adjusted admissions and reduced interest expense. A lowered 2022 outlook for EPS might be a concern for investors.
Community Health Systems (CYH) Surpasses Q1 Earnings Estimates
by Zacks Equity Research
Community Health Systems (CYH) delivered earnings and revenue surprises of 7.69% and 1.63%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Encompass Health (EHC) Relocates North Alabama Hospital
by Zacks Equity Research
Encompass Health (EHC) commences operations in its North Alabama hospital, which has been relocated with added capacity for better serving residents of the Huntsville community.
Ensign Group (ENSG) on Buyout Spree, Adds New Properties
by Zacks Equity Research
Ensign Group (ENSG) acquires the operations of certain living facilities in California and Washington to bolster its portfolio.
Community Health Systems (CYH) Down 4.7% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Community Health Systems (CYH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Retain Community Health (CYH) Stock
by Zacks Equity Research
With contract labor headwinds likely to phase out as 2022 progresses, Community Health Systems' (CYH) margins are set to improve significantly.
Encompass Health (EHC) Inaugurates New Hospital in Florida
by Zacks Equity Research
Encompass Health (EHC) increases its nationwide inpatient rehabilitation hospital count to 147 with the recently inaugurated 40-bed hospital in St. Augustine, FL.
Acadia Healthcare (ACHC) Q4 Earnings Miss on High Operating Costs
by Zacks Equity Research
Acadia Healthcare (ACHC) anticipates earnings per share within 62-66 cents for the March quarter of 2022.
Encompass Health (EHC) Ties Up to Better Serve Florida Residents
by Zacks Equity Research
Encompass Health (EHC) joins forces with Lee Health in a bid to construct two inpatient rehabilitation hospitals in Southwest Florida and deliver better health outcomes across the region.
Is Community Health Systems (CYH) a Suitable Value Stock Now?
by Zacks Equity Research
Let's see if Community Health Systems, Inc. (CYH) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Universal Health (UHS) Q4 Earnings Beat on Higher Patient Days
by Zacks Equity Research
Universal Health Services (UHS) expects capital expenditures for 2022 to increase from the 2021 level to the range of $950-$1,100 million.
Community Health's (CYH) Earnings Beat, Improve Y/Y in Q4
by Zacks Equity Research
Community Health's (CYH) fourth-quarter 2021 results gain from better revenues.
Community Health Systems (CYH) Surpasses Q4 Earnings Estimates
by Zacks Equity Research
Community Health Systems (CYH) delivered earnings and revenue surprises of 130% and 0.93%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Mednax (MD) Pursues $1.1B Transactions to Reduce Debt Burden
by Zacks Equity Research
Mednax (MD) issues senior notes, and a new revolving credit facility coupled with a term loan remains in place, which is aimed at reducing MD's debt level and associated interest expenses.
Should You Buy Community Health (CYH) Ahead of Earnings?
by Zacks Equity Research
Community Health (CYH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Community Health (CYH) Ties Up to Offer Enhanced Remote Care
by Zacks Equity Research
Community Health (CYH) teams up with Cadence highlighting its aim of utilizing innovative technology to extend enhanced remote care to patients.
Will Patient Days Drive Community Health (CYH) Q4 Earnings?
by Zacks Equity Research
Community Health Systems' (CYH) fourth-quarter results are likely to reflect a higher occupancy rate and average length of stay.
Community Health Systems (CYH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Community Health Systems (CYH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tenet Healthcare (THC) Q4 Earnings Beat Estimates
by Zacks Equity Research
Tenet (THC) delivered earnings and revenue surprises of 73.08% and 2.80%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Mednax (MD) Buys Night Lite Pediatrics to Boost Portfolio
by Zacks Equity Research
Mednax (MD) purchases Night Lite Pediatrics, LLC in Orlando to enhance its pediatric business line.
Centene (CNC) Gears Up for Q4 Earnings: What Lies Ahead?
by Zacks Equity Research
Centene's (CNC) fourth-quarter results are likely to reflect growth in total membership.
The Zacks Analyst Blog Highlights: Houlihan Lokey, Crocs and Community Health Systems
by Zacks Equity Research
Houlihan Lokey, Crocs and Community Health Systems are highlighted in this Analyst Blog article.
A Window to Buy 3 Great Stocks Ahead of Earnings
by Sejuti Banerjea
Things are coming together for HLI, CROX and CYH.
Retail Loss to Affect Humana's (HUM) Q4 Earnings: Here's How
by Zacks Equity Research
Humana's (HUM) fourth-quarter results are likely to reflect growth in medical membership.
Anthem's (ANTM) Q4 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
Anthem's (ANTM) Q4 results reflect better revenues and a solid contribution from its Government Business and IngenioRx businesses, partly offset by escalating expenses.